SCHEMBL4380774

SCHEMBL4380774

CCc1c(OC)cc(OC(=O)OC)c(-c2ccccc2)c1CC(=O)OC

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 2/20 0.39
KDM4E B2RXH2 2/20 0.39
HSD17B10 Q99714 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.37
NPC1 O15118 1/20 0.37
PKM P14618 1/20 0.37
NFKB1 P19838 1/20 0.37
RAB9A P51151 1/20 0.37
NFKB2 Q00653 1/20 0.37
RELA Q04206 1/20 0.37
ACLY P53396 1/20 0.36
ALDH1A1 P00352 3/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
CYP1A2 P05177 1/20 0.36
THRB P10828 1/20 0.36
BLM P54132 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
FABP4 P15090 2/20 0.35
FABP3 P05413 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4385012 0.86 L3MBTL1 (0.39) HPGDKDM4EHSD17B10SMN1; SMN2NPC1
SCHEMBL4381890 0.85 TSHR (0.40) HPGDKDM4EHSD17B10SMN1; SMN2NPC1
SCHEMBL4380484 0.84 ALDH1A1 (0.42) HPGDKDM4EHSD17B10SMN1; SMN2NPC1
SCHEMBL4385948 0.82 KDM4E (0.40) HPGDKDM4EHSD17B10SMN1; SMN2NPC1
SCHEMBL4379880 0.80 EGFR (0.42) HPGDKDM4ESMN1; SMN2NPC1PKM
SCHEMBL4380278 0.79 HPGD (0.42) HPGDKDM4ESMN1; SMN2NPC1RAB9A
SCHEMBL4380942 0.75 L3MBTL1 (0.43) HPGDKDM4ESMN1; SMN2NPC1PKM
SCHEMBL4384143 0.74 KDM4E (0.36) HPGDKDM4EHSD17B10PPARGPPARA
SCHEMBL4392454 0.73 ADORA3 (0.40) HPGDKDM4EHSD17B10SMN1; SMN2NPC1
SCHEMBL4389156 0.72 EGFR (0.46) HPGDKDM4ESMN1; SMN2NPC1PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7538241-B2 Hsp90 family protein inhibitors KYOWA HAKKO KOGYO CO., LTD. (JP) 2009-05-26 US disclosed
US-20070155813-A1 Hsp90 family protein inhibitors KYOWA HAKKO KOGYO CO., LTD. (JP) 2007-07-05 US disclosed
EP-1704856-A1 HSP90 FAMILY PROTEIN INHIBITOR KYOWA HAKKO KOGYO CO., LTD. (JP) 2006-09-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070155813-A1 Hsp90 family protein inhibitors HSP90AB1, HEATR1, HSP90AB2P HPGD 3238/4885KDM4E 3223/4885HSD17B10 405/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.